Publications 2018

Ahlgren GM, Flodgren P, Tammela TLJ, Kellokumpu-Lehtinen P, Borre M, Angelsen A, Iversen JR, Sverrisdottir A, Jonsson E, Sengelov L, Investigators of the Scandinavian Prostate Cancer Study Number 12 (2018)
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
Eur Urol, 73 (6), 870-876
DOI 10.1016/j.eururo.2018.01.012, PubMed 29395502

Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M (2018)
Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis
Cancer Treat Rev, 66, 23-44
DOI 10.1016/j.ctrv.2018.03.005, PubMed 29673922

Hayman J, Hole KH, Seierstad T, Perin J, DeWeese TL, Tran PT, Lilleby W (2018)
Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
Urol Oncol (in press)
DOI 10.1016/j.urolonc.2018.09.016, PubMed 30446451

Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV et al. (2018)
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
JAMA, 319 (9), 896-905
DOI 10.1001/jama.2018.0587, PubMed 29509865

Rogg L (2018)
NO MAN'S LAND For those who did not die, who are no longer sick, nor are they healthy
Tidsskr. Nor. Laegeforen., 138 (5), 483

Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM et al. (2018)
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Int J Radiat Oncol Biol Phys, 101 (4), 883-888
DOI 10.1016/j.ijrobp.2018.03.060, PubMed 29976500

Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2018)
Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Acta Radiol, 284185118810977 (in press)
DOI 10.1177/0284185118810977, PubMed 30379559

Wedde TB, Småstuen MC, Brabrand S, Fosså SD, Kaasa S, Tafjord G, Russnes KM, Hellebust TP, Lilleby W (2018)
Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort
Radiother Oncol (in press)
DOI 10.1016/j.radonc.2018.10.013, PubMed 30389241

Yachnin J, Gilje B, Thon K, Johansson H, Brandberg Y, Panaretakis T, Ullén A (2018)
Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
Eur J Cancer, 97, 33-40
DOI 10.1016/j.ejca.2018.03.007, PubMed 29685343

Publications 2017

Lilleby W, Gaudernack G, Brunsvig PF, Vlatkovic L, Schulz M, Mills K, Hole KH, Inderberg EM (2017)
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
Cancer Immunol Immunother, 66 (7), 891-901
DOI 10.1007/s00262-017-1994-y, PubMed 28391357

Publications 2016

Lilleby W, Stensvold A, Dahl AA (2016)
Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer
Acta Oncol, 55 (7), 807-13
DOI 10.3109/0284186X.2015.1127417, PubMed 26959297

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859

Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G, SWENOTECA (2016)
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
Ann Oncol, 27 (7), 1299-304
DOI 10.1093/annonc/mdw164, PubMed 27052649

Publications 2015

Lilleby W, Narrang A, Tafjord G, Vlatkovic L, Russnes KM, Stensvold A, Hole KH, Tran P, Eilertsen K (2015)
Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
Radiat Oncol, 10, 232
DOI 10.1186/s13014-015-0540-3, PubMed 26577452

Lilleby W, Raabe NK, Normann M (2015)
[Re: The problematical prostate cancer]
Tidsskr Nor Laegeforen, 135 (11), 1009
DOI 10.4045/tidsskr.15.0593, PubMed 26080763

Nilsen TS, Raastad T, Skovlund E, Courneya KS, Langberg CW, Lilleby W, Fosså SD, Thorsen L (2015)
Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy
Acta Oncol, 54 (10), 1805-13
DOI 10.3109/0284186X.2015.1037008, PubMed 25927504

Rogg LV (2015)
Medical humanities companion, vol 4, Prognosis
Tidsskr. Nor. Laegeforen., 135 (4), 358

Raabe NK, Normann M, Lilleby W (2015)
Low-dose-rate brachytherapy for low-grade prostate cancer
Tidsskr Nor Laegeforen, 135 (6), 548-52
DOI 10.4045/tidsskr.13.1404, PubMed 25806763

Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A (2015)
[Re: Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (12-13), 1105
DOI 10.4045/tidsskr.15.0652, PubMed 26130530

Storås AH, Sanda MG, Boronat OG, Chang P, Patil D, Crociani C, Suarez JF, Cvancarova M, Loge JH, Fosså SD (2015)
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients
Clin Genitourin Cancer, 14 (3), e265-73
DOI 10.1016/j.clgc.2015.10.009, PubMed 26778476

Publications 2014

Lilleby W, Stensvold A, Dahl AA (2014)
Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up
Acta Oncol, 53 (10), 1380-9
DOI 10.3109/0284186X.2014.916042, PubMed 24844918

Storås AH, Sanda MG, Ferrer M, Loge JH, Dahl AA, Steinsvik EA, Guedea F, Cvancarova M, Fosså SD (2014)
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment
Clin Genitourin Cancer, 12 (4), e117-25
DOI 10.1016/j.clgc.2013.12.007, PubMed 24524968

Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G, SWENOTECA (2014)
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
Ann Oncol, 25 (11), 2167-72
DOI 10.1093/annonc/mdu375, PubMed 25114021

Publications 2013

Karlsson R, Andreassen KE, Kristiansen W, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Magnusson PK, Adami HO, Haugen TB, Grotmol T, Wiklund F (2013)
Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4
Hum Mol Genet, 22 (16), 3373-80
DOI 10.1093/hmg/ddt188, PubMed 23640991

Lilleby W, Stensvold A, Dahl AA (2013)
Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of life
Prostate, 73 (10), 1038-47
DOI 10.1002/pros.22651, PubMed 23532709

Ragnum HB, Røe K, Holm R, Vlatkovic L, Nesland JM, Aarnes EK, Ree AH, Flatmark K, Seierstad T, Lilleby W, Lyng H (2013)
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
Int J Radiat Oncol Biol Phys, 87 (4), 753-60
DOI 10.1016/j.ijrobp.2013.07.023, PubMed 24035332

Publications 2012

Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB (2012)
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
Hum Reprod, 27 (5), 1525-35
DOI 10.1093/humrep/des075, PubMed 22402210

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
Bother problems in prostate cancer patients after curative treatment
Urol Oncol, 31 (7), 1067-78
DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412

Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, Sigurdsson F, Kure E, Ikdahl T, Skovlund E, Fokstuen T, Hansen F, Hofsli E, Birkemeyer E, Johnsson A, Starkhammar H, Yilmaz MK, Keldsen N, Erdal AB, Dajani O, Dahl O, Christoffersen T (2012)
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study
J Clin Oncol, 30 (15), 1755-62
DOI 10.1200/JCO.2011.38.0915, PubMed 22473155

Publications 2011

Lilleby W, Tafjord G, Raabe NK (2011)
Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancer
Int J Radiat Oncol Biol Phys, 83 (3), 933-9
DOI 10.1016/j.ijrobp.2011.08.028, PubMed 22138456

Lilleby W, Willoch F, Stensvold A (2011)
Detection of prostate cancer relapse with PET/CT using a novel radiotracer
Acta Oncol, 51 (3), 397-9
DOI 10.3109/0284186X.2011.614638, PubMed 21936756

Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
J Clin Oncol, 29 (15), 2032-9
DOI 10.1200/JCO.2010.29.1278, PubMed 21482994

Rogne SG, Rønning P, Helseth E, Johannesen TB, Langberg CW, Lote K, Scheie D, Meling TR (2011)
Craniotomy for brain metastases: a consecutive series of 316 patients
Acta Neurol Scand, 126 (1), 23-31
DOI 10.1111/j.1600-0404.2011.01590.x, PubMed 21902675

Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress
J Psychosom Res, 70 (5), 403-10
DOI 10.1016/j.jpsychores.2010.12.004, PubMed 21511070

Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S (2011)
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
Prostate, 72 (6), 668-76
DOI 10.1002/pros.21470, PubMed 21809351

Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G (2011)
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group
J Clin Oncol, 29 (6), 719-25
DOI 10.1200/JCO.2010.30.1044, PubMed 21205748

Wedde TB, Lobmaier IV, Brennhovd B, Lohne F, Hall KS (2011)
Primary Ewing's Sarcoma of the Kidney in a 73-Year-Old Man
Sarcoma, 2011, 978319
DOI 10.1155/2011/978319, PubMed 21776194

Publications 2010

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD (2010)
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
J Clin Oncol, 28 (30), 4649-57
DOI 10.1200/JCO.2010.29.9362, PubMed 20855830

Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2010)
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733

Rogg L, Aasland OG, Graugaard PK, Loge JH (2010)
Direct communication, the unquestionable ideal? Oncologists' accounts of communication of bleak prognoses
Psychooncology, 19 (11), 1221-8
DOI 10.1002/pon.1691, PubMed 20186873

Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2010)
A prospective study of neuropsychological functioning in testicular cancer patients
Ann Oncol, 22 (5), 1062-70
DOI 10.1093/annonc/mdq553, PubMed 21048038

Publications 2009

Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
[Incorrect about hormone treatment in prostatic cancer]
Tidsskr Nor Laegeforen, 129 (5), 429
DOI 10.4045/tidsskr.08.0649, PubMed 19247406

Rogg L, Loge JH, Aasland OG, Graugaard PK (2009)
Physicians' attitudes towards disclosure of prognostic information: a survey among a representative cross-section of 1605 Norwegian physicians
Patient Educ Couns, 77 (2), 242-7
DOI 10.1016/j.pec.2009.03.007, PubMed 19356882

Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH (2009)
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema
Acta Radiol, 50 (6), 682-9
DOI 10.1080/02841850902933123, PubMed 19449234

Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, Langberg C, Bremnes RM, Laurell A, Wijkstrøm H, Klepp O (2009)
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program
J Clin Oncol, 27 (13), 2122-8
DOI 10.1200/JCO.2008.18.8953, PubMed 19307506

Publications 2008

Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
Prostate, 68 (15), 1607-14
DOI 10.1002/pros.20826, PubMed 18655095

Raabe NK, Lilleby W, Tafjord G, Aström L (2008)
[High dose rate brachytherapy in prostate cancer in Norway]
Tidsskr Nor Laegeforen, 128 (11), 1275-8
PubMed 18511969

Steinsvik EA, Fosså SD, Lilleby W, Eilertsen K (2008)
Fertility issues in patients with prostate cancer
BJU Int, 102 (7), 793-5
DOI 10.1111/j.1464-410X.2008.07739.x, PubMed 18489529

Publications 2007

Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
Int J Cancer, 120 (8), 1603-9
DOI 10.1002/ijc.22488, PubMed 17230512

Berg A, Lilleby W, Bruland OS, Fosså SD (2007)
10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
DOI 10.1016/j.ijrobp.2007.04.031, PubMed 17703896

Fosså SD, Jacobsen AB, Ginman C, Jacobsen IN, Overn S, Iversen JR, Urnes T, Dahl AA, Veenstra M, Sandstad B (2007)
Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study
Eur Urol, 52 (6), 1691-8
DOI 10.1016/j.eururo.2007.01.104, PubMed 17306441

Lilleby W (2007)
Use of bisphosphonates in advanced prostate cancer: Current status
Indian J Urol, 23 (1), 54
DOI 10.4103/0970-1591.30268, PubMed 19675764

Lilleby W, Axcrona K, Alfsen GC, Urnes T, Hole KH (2007)
Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate
Acta Oncol, 46 (8), 1195-7
DOI 10.1080/02841860701367886, PubMed 17851841

Publications 2006

Lilleby W, Hernes E, Waehre H, Raabe N, Fosså SD (2006)
[Treatment of hormone-resistant prostate cancer]
Tidsskr Nor Laegeforen, 126 (21), 2798-801
PubMed 17086220

Rogg L, Graugaard PK, Loge JH (2006)
Physicians' interpretation of the prognostic term "terminal": a survey among Norwegian physicians
Palliat Support Care, 4 (3), 273-8
PubMed 17066968

Publications 2005

Bassarova AV, Nesland JM, Sedloev T, Lilleby W, Hristova SL, Trifonov DY, Torlakovic E (2005)
Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53
Int J Surg Pathol, 13 (3), 239-46
DOI 10.1177/106689690501300302, PubMed 16086078

Lilleby W, Sudbø J, Fosså SD (2005)
[Biology and treatment options during the development of prostate cancer]
Tidsskr Nor Laegeforen, 125 (5), 571-4
PubMed 15776028

Torlakovic E, Lilleby W, Berner A, Torlakovic G, Chibbar R, Furre T, Fosså SD (2005)
Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma
Int J Cancer, 117 (3), 381-6
DOI 10.1002/ijc.21174, PubMed 15900599

Publications 2003

Brustugun OT, Nome O, Bruland S ØS, Ottestad L, Lilleby W (2003)
[Breast cancer patients' assessment of waiting time before radiotherapy]
Tidsskr Nor Laegeforen, 123 (12), 1685-6
PubMed 12821991

Fosså SD, Lilleby W, Waehre H, Berner A, Torlakovic G, Paus E, Olsen DR (2003)
Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy
Int J Radiat Oncol Biol Phys, 57 (1), 33-41
DOI 10.1016/S0360-3016(03)00428-0, PubMed 12909213

Lilleby W, Dale E, Olsen DR, Gude U, Fosså SD (2003)
Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose
Acta Oncol, 42 (1), 10-4
DOI 10.1080/0891060310002177, PubMed 12665325

Lilleby W, Nesland JM, Fosså SD, Torlakovic G, Waehre H, Kvalheim G (2003)
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
Int J Cancer, 103 (1), 91-6
DOI 10.1002/ijc.10780, PubMed 12455058

Publications 2002

Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A (2002)
Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
Int J Cancer, 99 (1), 100-5
DOI 10.1002/ijc.10286, PubMed 11948499

Torlakovic E, Lilleby W, Torlakovic G, Fosså SD, Chibbar R (2002)
Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score
Hum Pathol, 33 (6), 646-51
DOI 10.1053/hupa.2002.124033, PubMed 12152165

Publications 2001

Lilleby W, Paus E, Skovlund E, Fosså SD (2001)
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer
Prostate, 46 (2), 126-33
PubMed 11170140

Lilleby W, Torlakovic G, Torlakovic E, Skovlund E, Fosså SD (2001)
Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy
Cancer, 92 (2), 311-9
DOI 10.1002/1097-0142(20010715)92:2<311::AID-CNCR1324>3.0.CO;2-H, PubMed 11466684

Publications 2000

Denham JW, Hauer-Jensen M, Kron T, Langberg CW (2000)
Treatment-time-dependence models of early and delayed radiation injury in rat small intestine
Int J Radiat Oncol Biol Phys, 48 (3), 871-87
DOI 10.1016/S0360-3016(00)00708-2, PubMed 11020586

Langberg CW, Solheim S, Hagen S (2000)
[Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?]
Tidsskr Nor Laegeforen, 120 (6), 707-10
PubMed 10806885

Lilleby W, Fosså SD, Knutsen BH, Abildgaard A, Skovlund E, Lien HH (2000)
Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation
Radiother Oncol, 57 (2), 195-200
DOI 10.1016/S0167-8140(00)00219-X, PubMed 11054523

Publications 1999

Bakken AM, Ogreid P, Iversen J, Langberg CW (1999)
[Normal tissue radiation toxicity in radiotherapy of localized prostatic cancer]
Tidsskr Nor Laegeforen, 119 (14), 2017-21
PubMed 10394276

Lilleby W, Fosså SD, Waehre HR, Olsen DR (1999)
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
Int J Radiat Oncol Biol Phys, 43 (4), 735-43
DOI 10.1016/S0360-3016(98)00475-1, PubMed 10098428

Lilleby W, Olsen DR, Foss a SD (1999)
Comparison of radiation side-effects in prostate cancer
Lancet, 353 (9162), 1443
DOI 10.1016/S0140-6736(05)75969-9, PubMed 10227249

Publications 1997

Jensen JL, Langberg CW (1997)
[Temporary radiation-induced hypo-salivation in a child]
Tidsskr Nor Laegeforen, 117 (21), 3077-9
PubMed 9381440

Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE (1997)
Combined modality treatment including IORT in locally advanced and recurrent rectal cancer: results from a prospective Norwegian study
Front Radiat Ther Oncol, 31, 221-3
PubMed 9263827

Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE (1997)
Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer
Radiother Oncol, 44 (3), 277-82
DOI 10.1016/S0167-8140(97)00070-4, PubMed 9380828

Publications 1996

Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M (1996)
Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy
Acta Oncol, 35 (1), 81-7
DOI 10.3109/02841869609098484, PubMed 8619945

Publications 1995

Olsen DR, Paulsen TH, Heyerdal H, Tveit KM, Wiig JN, Giercksky KE, Storaas A (1995)
Field homogeneity of bevelled intraoperative electron beam cones: the influence of virtual focus surface distance
Med Dosim, 20 (2), 105-9
PubMed 7632342

Scott BR, Langberg CW, Hauer-Jensen M (1995)
Models for estimating the risk of ulcers in the small intestine after localized single or fractionated irradiation
Br J Radiol, 68 (805), 49-57
DOI 10.1259/0007-1285-68-805-49, PubMed 7881883

Publications 1994

Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M (1994)
Influence of fractionation schedule on development of intestinal complications following localized irradiation. An experimental study in the rat
Acta Oncol, 33 (4), 403-8
DOI 10.3109/02841869409098436, PubMed 8018373

Publications 1992

Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M (1992)
Tolerance of rat small intestine to localized single dose and fractionated irradiation
Acta Oncol, 31 (7), 781-7
DOI 10.3109/02841869209083871, PubMed 1476759

Publications 1984

Langberg CW, Barkve H, Tjørstad K (1984)
[Cryptococcus neoformans meningoencephalitis]
Tidsskr Nor Laegeforen, 104 (14), 968-70
PubMed 6087494

 
Page visits: 216